1. Home
  2. CYTK vs NFG Comparison

CYTK vs NFG Comparison

Compare CYTK & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • NFG
  • Stock Information
  • Founded
  • CYTK 1997
  • NFG 1902
  • Country
  • CYTK United States
  • NFG United States
  • Employees
  • CYTK 564
  • NFG N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • NFG Oil/Gas Transmission
  • Sector
  • CYTK Health Care
  • NFG Utilities
  • Exchange
  • CYTK Nasdaq
  • NFG Nasdaq
  • Market Cap
  • CYTK 5.8B
  • NFG 5.8B
  • IPO Year
  • CYTK 2004
  • NFG N/A
  • Fundamental
  • Price
  • CYTK $48.87
  • NFG $59.92
  • Analyst Decision
  • CYTK Buy
  • NFG Buy
  • Analyst Count
  • CYTK 16
  • NFG 2
  • Target Price
  • CYTK $84.07
  • NFG $72.50
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • NFG 541.3K
  • Earning Date
  • CYTK 11-06-2024
  • NFG 02-05-2025
  • Dividend Yield
  • CYTK N/A
  • NFG 3.44%
  • EPS Growth
  • CYTK N/A
  • NFG N/A
  • EPS
  • CYTK N/A
  • NFG 0.84
  • Revenue
  • CYTK $3,219,000.00
  • NFG $1,944,810,000.00
  • Revenue This Year
  • CYTK N/A
  • NFG $26.54
  • Revenue Next Year
  • CYTK $795.25
  • NFG $5.89
  • P/E Ratio
  • CYTK N/A
  • NFG $71.35
  • Revenue Growth
  • CYTK N/A
  • NFG N/A
  • 52 Week Low
  • CYTK $43.21
  • NFG $45.32
  • 52 Week High
  • CYTK $110.25
  • NFG $65.06
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • NFG 41.72
  • Support Level
  • CYTK $45.66
  • NFG $59.05
  • Resistance Level
  • CYTK $49.40
  • NFG $61.00
  • Average True Range (ATR)
  • CYTK 1.71
  • NFG 1.13
  • MACD
  • CYTK -0.20
  • NFG -0.32
  • Stochastic Oscillator
  • CYTK 50.79
  • NFG 21.98

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

Share on Social Networks: